Company Overview

Company name: The Puration
Description: Developer of standardized and repeatable cannabis extraction processes intended to deliver a consistent and high quality concentrate for infusion into consumer food and beverage products. The company’s water purification business is secondary and the development of a leading cannabinoid extraction capacity is the primary focus with extracts infused into a sports and fitness nutritional supplement line.
Year founded: 2011
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Website: www.purationinc.com
Employees: 4
City: Dallas
State: Texas
Country: United States
Region: Americas

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Acquired/Merged
Exchange:
Ticker:
Revenue (USD Million):
Gross profit (USD Million): 0.51
Net income (USD Million) -4.54
Enterprise value: 2.51
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period: TTM 3Q2007
Financing Status: The company was acquired by American Cannabis Innovations Conglomerated, via its undisclosed financial sponsor, through an LBO on June 7, 2017. The common stock of PURA will remain traded on the OTC Markets with no forward or reverse split taking place in conjunction with the ACI transaction. ACI expects the potential for market capitalizations of PURA to improve by transitioning the Company toward better investment structures, with better terms, that are altogether better suited to the current and more mature stage of development.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation:
Last known valuation date: